EUVIMEDEUVIMED entdecken
Crossref

The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History

Yaşa Gül Mutlu, Şerife Emre Ünsal, Buse Güleç, İstemi Serin, Eren Arslan Davulcu, Gülçin Miyase Sönmez, Serkan Güven, Süreyya Yiğit Kaya, Senem Maral, Muzaffer Keklik, Ayşe Salihoğlu, Tugba Cetintepe und 2 weitere

Clinical Lymphoma Myeloma and Leukemia · 2026

DOI: 10.1016/j.clml.2025.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026. Verfasst von Yaşa Gül Mutlu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Gaziantep City Hospital, Gaziantep, Turkey. Electronic address: yasagulmutlu@hotmail.com. Hauptthemen laut MEDLINE: Multiple Myeloma, Neoplasms, Multiple Primary. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The coexistence of solid tumors and multiple myeloma (MM) presents diagnostic and therapeutic challenges; however, data on clinical outcomes in this population remain limited. This study aimed to evaluate the clinical characteristics and survival outcomes of patients with newly diagnosed multiple myeloma (NDMM) who had synchronous or prior solid tumor malignancies. METHODS: A retrospective analysis was conducted on 41 NDMM patients with a documented history of solid tumor, classified as either concurrent (diagnosed within 6 months) or prior. Clinical characteristics, treatment patterns, and outcomes were evaluated. Patients were stratified according to the timing of solid tumor diagnosis. RESULTS: The median age was 66 years, with a male predominance (58.5%). Breast (24.4%), lung (17.1%), colon, and prostate cancers (9.8% each) were the most common solid tumors. Extramedullary disease was observed only in the synchronous group (100% vs. 0%). Autologous transplantation was performed significantly less frequently in the synchronous group (26.3% vs. 73.7%, P = 0.041). Lenalidomide maintenance therapy was underutilized in patients with synchronous malignancies, reflecting possible clinical hesitation. Myeloma-related mortality occurred in 17.1% of patients, with a median overall survival of 48 months (range: 16-80), and no significant survival difference between synchronous and patient with prior solid tumor history group. CONCLUSION: The presence of synchronous solid tumors in NDMM patients is associated with a higher rate of extramedullary disease and may influence clinical decision-making, highlighting the need for multidisciplinary management and individualized treatment strategies. Furthermore, extramedullary involvement in MM should prompt evaluation for a potential coexisting solid malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaNeoplasms, Multiple PrimaryHumansMaleAgedFemaleRetrospective StudiesMiddle AgedAged, 80 and overTreatment OutcomeAdult

Autor:innen und Institutionen

  • Department of Hematology, Gaziantep City Hospital, Gaziantep, Turkey. Electronic address: yasagulmutlu@hotmail.com.
  • Department of Hematology, Erciyes University, Kayseri, Turkey.
  • Department of Hematology, Cerrahpasa University, Istanbul, Turkey.
  • Department of Hematology, University of Health Sciences, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
  • University of Health Sciences Türkiye, İstanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital, Clinic of Hematology, İstanbul, Türkiye.
  • Department of Hematology, Ankara University, Ankara, Turkey.

Zitieren

APA

Mutlu, Y. G., Emre Ünsal, Ş., Güleç, B., Serin, İ., Arslan Davulcu, E., Sönmez, G. M., Güven, S., Yiğit Kaya, S., Maral, S., Keklik, M., Salihoğlu, A., Cetintepe, T., Cengiz Seval, G., & Sevindik, Ö. G. (2026). The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.10.006

Vancouver

Mutlu YG, Emre Ünsal Ş, Güleç B, Serin İ, Arslan Davulcu E, Sönmez GM, et al. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clinical Lymphoma Myeloma and Leukemia. 2026. doi:10.1016/j.clml.2025.10.006

BibTeX
@article{Mutlu2026,
  author = {Mutlu, Yaşa Gül and Emre Ünsal, Şerife and Güleç, Buse and Serin, İstemi and Arslan Davulcu, Eren and Sönmez, Gülçin Miyase and Güven, Serkan and Yiğit Kaya, Süreyya and Maral, Senem and Keklik, Muzaffer and Salihoğlu, Ayşe and Cetintepe, Tugba and Cengiz Seval, Güldane and Sevindik, Ömür Gökmen},
  title = {The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  doi = {10.1016/j.clml.2025.10.006}
}
Kostenlos starten →